Internal Medicine

Top Story

FDA warns company for selling unapproved CBD products to treat Alzheimer’s, cancer, opioid withdrawal

FDA warns company for selling unapproved CBD products to treat Alzheimer’s, cancer, opioid withdrawal
July 23, 2019
In the Journals

High-risk patients unable to take PCSK9 inhibitors have poor outcomes

July 23, 2019
Among high-risk patients prescribed PCSK9 inhibitors, those whose prescriptions were rejected by payers or who abandoned their prescriptions had worse outcomes compared…
In the Journals

USPSTF: Screen pregnant women for hepatitis B

July 23, 2019
The U.S. Preventive Services Task Force recently gave an ‘A’ level recommendation to screening women for hepatitis B in their first trimester of pregnancy…
In the Journals

Filgotinib improves RA signs, symptoms in DMARD-refractory patients

July 23, 2019
Patients with rheumatoid arthritis who previously had an inadequate response to biologic DMARDs demonstrated improved signs and symptoms after receiving daily doses of…
More Headlines »